| Heading: |
Respiratory Syncytial Virus: Vaccination |
| Question ID: |
1795948 |
| UIN: |
HL6739 |
| House: |
Lords |
| Date tabled: |
2025-04-22 |
| Asking Member ID: |
4130 |
| Asking Member display name: |
Baroness Ritchie of Downpatrick
|
| Asking Member handle: |
MRitchieSD
|
| Asking Member Twitter reference: |
@MRitchieSD
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what assessment they have made of the coverage rates and impact on hospitalisations of the maternal vaccination programme for respiratory syncytial virus; and what steps are being taken to improve them. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-30 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The UK Health Security Agency (UKHSA) monitors trends in vaccine coverage. Trends in maternal respiratory syncytial virus (RSV) vaccine uptake are published on the GOV.UK website.The UKHSA also undertakes monitoring and evaluation of immunisation programm... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |